Search

Twist Bioscience Corp

Închisă

SectorSănătate

141.55 3.98

Rezumat

Modificarea prețului

24h

Curent

Minim

131.32

Maxim

138.52

Indicatori cheie

By Trading Economics

Venit

9M

-35M

Vânzări

7.7M

118M

EPS

-0.56

Marjă de profit

-29.61

Angajați

979

EBITDA

9.8M

-28M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

-19.48% downside

Dividende

By Acuity

Următoarele câștiguri

13 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

1.5B

7.8B

Deschiderea anterioară

137.57

Închiderea anterioară

141.55

Sentimentul știrilor

By Acuity

50%

50%

112 / 339 Clasament în Healthcare

Twist Bioscience Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 sept. 2026, 20:07 UTC

Twist Bioscience Corp is higher during Monday's session, recovering from earlier losses. No specific news was identified to explain the price movement.

11 sept. 2026, 20:08 UTC

Social Media

Twist Bioscience shares are higher after being identified for bullish potential, supported by a MACD pinch technical indicator. The stock advanced despite earlier session dips.

10 sept. 2026, 23:01 UTC

Twist Bioscience Corp shares are trading higher in after-market hours. No specific news was identified to explain the movement.

9 sept. 2026, 20:07 UTC

News
Correlated Moves

Twist Bioscience shares are lower as BWS Financial initiates coverage with a Sell rating, contrasting UBS's Neutral rating and higher price target of $144.00.

8 sept. 2026, 20:07 UTC

News
Social Media

Twist Bioscience Corp shares are higher, driven by increased recognition of AI applications in healthcare and a "Moderate Buy" consensus rating from brokerages.

3 sept. 2026, 19:36 UTC

News

Twist Bioscience reported $118.4 million in Q3 revenue and raised its guidance, yet shares are lower, continuing a five-session decline.

2 sept. 2026, 23:06 UTC

Twist Bioscience Corp. shares are lower in after-market hours, extending a trend of five consecutive daily declines. Earlier, the stock briefly rose before falling again.

1 sept. 2026, 19:56 UTC

Correlated Moves

Twist Bioscience Corp shares are lower amid broader market pressures and rising Treasury yields. The Russell 2000 Index also declined during Tuesday's session.

31 aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, following no specific news. The stock remains above its 20-day moving average.

28 aug. 2026, 22:51 UTC

Twist Bioscience shares are higher in after-market trading. Rising Treasury yields may be influencing investor sentiment in the biotechnology sector.

27 aug. 2026, 23:02 UTC

Twist Bioscience shares are higher in after-market hours, recovering from earlier losses. Jobless claims data suggests strength in the labor market.

26 aug. 2026, 19:36 UTC

Twist Bioscience Corp shares are trading higher today, maintaining a position near the upper end of their one-month range. No specific news has been identified.

25 aug. 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market hours, rebounding from a post-close low amid broader market support from falling crude oil prices and treasury yields.

24 aug. 2026, 23:51 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining gains from earlier in the session and staying above key moving averages.

21 aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, despite remaining well above their 20-day moving average and last month's price levels.

20 aug. 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading. Broader market pressures, including rising crude oil prices and geopolitical tensions, may be influencing sentiment.

19 aug. 2026, 23:06 UTC

News
Correlated Moves

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

18 aug. 2026, 23:21 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining an upward trend and positioned above its 20-day moving average.

17 aug. 2026, 22:36 UTC

Twist Bioscience Corp shares are slightly higher in after-market hours, maintaining strong performance above their 20-day moving average despite earlier declines.

14 aug. 2026, 19:06 UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

13 aug. 2026, 23:06 UTC

Correlated Moves

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

12 aug. 2026, 19:16 UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

11 aug. 2026, 23:46 UTC

Correlated Moves

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.

10 aug. 2026, 20:03 UTC

News
Social Media

Twist Bioscience Corp shares are higher today, buoyed by positive social media sentiment and a notable increase in trading volume since Friday's close.

7 aug. 2026, 19:51 UTC

Twist Bioscience Corp shares are higher during Friday's session, with strong market activity and unusually high volume. No specific news explains this movement.

6 aug. 2026, 22:56 UTC

Twist Bioscience Corp shares are higher in after-market trading, reflecting positive momentum since Thursday's close amid broader economic data indicating labor market strength.

5 aug. 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 aug. 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 aug. 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 iul. 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

Comparație

Modificare preț

Twist Bioscience Corp Așteptări

Obiectiv de preț

By TipRanks

-19.48% jos

Prognoză pe 12 luni

Medie 108.5 USD  -19.48%

Maxim 144 USD

Minim 45 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTwist Bioscience Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

8

Cumpărare

2

Păstrare

1

Vânzare

Sentiment

By Acuity

112 / 339 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat